mayoclinic.org/phoenix-hematologyoncology
P. Leif Bergsagel, MD, earned his medical degree from the University of Toronto and completed his internship and residency at Sunnybrook Medical Centre, Toronto and Stanford University. He completed his medical oncology fellowship at the National Cancer Institute in Bethesda. Dr. Bergsagel is co-director of the Hematologic Malignancies Program at the Mayo Clinic Comprehensive Cancer Center. Dr. Bergsagel is a member of the National Cancer Institute Myeloma Steering Committee and serves as principal investigator for National Cancer Institute research grants for the Mayo Clinic in Multiple Myeloma, and the Cancer Moonshot in Myeloma Drug Resistance. His focus is the treatment of patients with amyloidosis, monoclonal gammopathy, multiple myeloma, and Waldenstrom’s macroglobulinemia.
U.S. News & World Report ranks Mayo Clinic #1 hospital in Arizona.
